3 hrs ago
Mid-Day Market Update: Red Hat Surges On Upbeat Results; CarMax Shares Decline
Midway through trading Friday, the Dow traded up 0.48 percent to 16,255.95 while the NASDAQ surged 0.98 percent to 4,097.77.
7 hrs ago
The Motley Fool
Why Jazz Pharma Shares Jumped
Although we don't believe in timing the market or panicking over market movements, we do like to keep an eye on big changes -- just in case they're material to our investing thesis.
11 hrs ago
NASDAQ Gainers Watch List: Gilead Sciences Inc. (NASDAQ:GILD) and...
Growing Stock Report expands its NASDAQ Gainers Weekly Watch List adding Gilead Sciences Inc. and Jazz Pharmaceuticals Public Limited Company .
16 hrs ago
2 Big Biotechs Moving Up On News
The biotech sector has been one of the best performing ones during the impressive rally of 2013.
Jazz Pharmaceuticals and Gentium S.p.A. Announce Agreement for Jazz...
Jazz Pharmaceuticals and Gentium S.p.A. Announce Agreement for Jazz Pharmaceuticals to Acquire Gentium for $57.00 Per Share Transaction would add a significant growth product in the European Union and Rest of World markets, Defitelio , a treatment for severe hepatic veno-occlusive disease in adults and children undergoing hematopoietic stem cell ... (more)
Jazz Pharmaceuticals Plc Stock Rating Lowered by Goldman Sachs Group Inc.
They currently have a $123.00 price objective on the stock, up from their previous price objective of $105.00.
Jazz Pharmaceuticals: Is It Really Worth $200?
Over a five-year period of time, only Pharmacyclics has performed better than Jazz Pharmaceuticals .
Jazz Pharma worth almost $200 - FBR
FBR Capital's William Tanner reiterates his Outperform rating and $198 price target on Jazz Pharmaceuticals , saying the stock remains his top pick in biopharma.